Peoples Financial Services Corp. (PFIS) Market Cap & Valuation Ratios
Peoples Financial Services Corp. (PFIS) has a market cap of $707.5M, a trailing P/E of 12.5 and a price-to-sales ratio of 3.6, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PFISPeoples Financial Services Corp.Follow PFIS — free
—
Price chart with a free account
- Market cap
- 707.5M
- P/E TTM
- 12.5
- Dividend yield
- 3.5%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Peers
banks - regional · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | P/B | ROE | Div. yield | Rev. growth |
|---|---|---|---|---|---|---|
| PFIS | 0.7 | 12.5 | 1.32 | 11% | 3.5% | +7% |
| WASH | 0.7 | 13.5 | 1.34 | 10% | 5.7% | +100% |
| AROW | 0.7 | 12.4 | 1.59 | 12% | 3.1% | +17% |
| BCAL | 0.7 | 11.9 | 1.21 | 11% | 1.4% | +4% |
| CWBC | 0.7 | 19.5 | 1.16 | 7% | 1.8% | +20% |
| CCB | 0.7 | — | 1.49 | -0.8% | — | +10% |
| MSBI | 0.7 | 21.1 | 1.20 | 8% | 3.9% | -4% |
| RRBI | 0.7 | 14.9 | 1.77 | 13% | 0.8% | +13% |
| BHB | 0.7 | 13.6 | 1.23 | 10% | 3.2% | +29% |
| CARE | 0.7 | 5.3 | 1.26 | 27% | — | +78% |
| CBNK | 0.7 | 12.1 | 1.59 | 14% | 1.2% | +15% |
| Median of these 10 | 13.5 | 1.30 | 10% | 2.5% | +16% |
P/E 12.5 vs. a peer median of 13.5; P/B 1.32 vs. 1.30. PFIS's own P/E sits at the 73rd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesCCB has no P/E (earnings not positive) and is left out · hover or tap a dot for values.
Peoples Financial Services Corp. — questions
- What is Peoples Financial Services Corp.'s market cap?
- $707.5M.
- What is Peoples Financial Services Corp.'s P/E ratio?
- 12.5 on trailing twelve-month earnings to 2026-06-30.
- What is Peoples Financial Services Corp.'s price-to-sales ratio?
- 3.6.
Every figure on this page comes from Peoples Financial Services Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.